vigabatrin has been researched along with Leukodystrophy, Metachromatic in 1 studies
Leukodystrophy, Metachromatic: An autosomal recessive metabolic disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to intralysosomal accumulation of cerebroside sulfate (SULFOGLYCOSPHINGOLIPIDS) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the GLIAL CELLS. There are several allelic and nonallelic forms with a variety of neurological symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurlemann, G | 1 |
| Palm, DG | 1 |
1 other study available for vigabatrin and Leukodystrophy, Metachromatic
| Article | Year |
|---|---|
Vigabatrin in metachromatic leucodystrophy; positive influence on spasticity.
Topics: Aminocaproates; Anticonvulsants; Child, Preschool; Humans; Leukodystrophy, Metachromatic; Male; Musc | 1991 |